U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07094204) titled 'A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors' on July 23.
Brief Summary: Genes contain genetic code which tell the body which proteins to make. Many types of cancer are caused by changes, or mutations, in a gene called KRAS. Researchers are looking for ways to stop the actions of abnormal proteins made from the mutated KRAS gene.
ASP5834 is being studied in people with solid tumors who have certain KRAS gene mutations. Some people with solid tumors of the colon or rectum (colorectal cancer), will be given ASP5834 with panitumumab. Panitumumab is a treatment for colorectal cancer. In this study, the researc...